Page last updated: 2024-10-26

dipyridamole and Aseptic Necrosis of Femur Head

dipyridamole has been researched along with Aseptic Necrosis of Femur Head in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Golopatiuk, AS2
Sharafutdinov, EN1

Other Studies

2 other studies available for dipyridamole and Aseptic Necrosis of Femur Head

ArticleYear
[Acid-base equilibrium and blood gases in patients with aseptic necrosis of the femur head during treatment with curantyl (dipyridamole)].
    Klinicheskaia meditsina, 1988, Volume: 66, Issue:10

    Topics: Acid-Base Equilibrium; Adult; Carbon Dioxide; Dipyridamole; Female; Femur Head Necrosis; Humans; Hyd

1988
[Conservative treatment of aseptic necrosis of the femur head with curantyl].
    Ortopediia travmatologiia i protezirovanie, 1988, Issue:6

    Topics: Adult; Dipyridamole; Female; Femur Head Necrosis; Humans; Infusions, Intravenous; Isotonic Solutions

1988